SecBot SecBot
COURT-RULING ·Filed Sep 14, 2026

ABBV

AbbVie Inc.
NEUTRAL
Impact Not scored
Horizondays Processed2mo ago CourtCourt Ruling · govinfo.gov
Court ruling (district)
Actionable Insight • Neutral

New Mexico federal court denied AbbVie's motion for a preliminary injunction against H.B. 78, a state law restricting manufacturer data demands in the 340B program. The ruling rejects AbbVie's federal preemption arguments, allowing the state law to proceed. Financial impact is limited near-term: the law is narrow (New Mexico only), the federal Rebate Program is not yet operative, and the ruling is a preliminary denial, not a final merits decision. The stock has historically absorbed similar neutral rulings without sustained downside.

DirectionNeutral
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20
Entry
$261.43
T+0 close · Sep 15, 2026 · via day close
Latest settled
+4.30%
T+20 · $272.69 · next T+60 in 22d
Vs SPY
+1.33%
α at T+20
Latest observation
+15.22%
T+43 · FF3 residual α
  1. T+0 · Sep 15 $261.43entry
  2. T+1 · 2mo ago −0.20%α +0.24% · $260.91
  3. T+5 · 8w ago +0.82%α −1.54% · $263.59
  4. T+20 · 5w ago +4.30%α +1.33% · $272.69
  5. T+44 · todayOpen
  6. T+60 · in 22d Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

New Mexico federal court denied AbbVie's motion for a preliminary injunction against H.B. 78, a state law restricting manufacturer data demands in the 340B program. The ruling rejects AbbVie's federal preemption arguments, allowing the state law to proceed. Financial impact is limited near-term: the law is narrow (New Mexico only), the federal Rebate Program is not yet operative, and the ruling is a preliminary denial, not a final merits decision. The stock has historically absorbed similar neutral rulings without sustained downside.

Financial Impact

Not specified

Market Snapshot

Price
$263.00
Volume
100
Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
82% bullish (39 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 court opinion.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-266eea10b1-ABBV

Track record

22 reports on ABBV

Performance horizon

7 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +27.21% at T+60 after the Apr 29, 2026 report. 7 of 9 went positive at some point.

Filters
  1. Nov 9, 20267d ago 144 Neutral 2/10 Entry $293.89 Now $294.55 +0.22% settles Dec 9
  2. Nov 2, 202614d ago 8-K Neutral 2/10 Entry $286.00 Now $294.55 +2.99% settles Dec 2
  3. Oct 30, 202617d ago 8-K Bullish 6/10 Entry $294.89 Now $294.55 −0.12% settles Nov 30
  4. Oct 29, 202619d ago Court Ruling Bullish 7/10 Entry $294.89 Now $294.55 −0.12% settles Nov 30
  5. Oct 16, 20264w ago Institutional Cluster Bullish 4/10 Entry $282.68 to $294.55 Now $294.55 +4.20% ▲ +4.20% +7.66% vs SPY
  6. Oct 15, 20264w ago 8-K Neutral 2/10 Entry $285.42 to $295.03 Now $294.55 +3.20% ▲ +3.37% +4.53% vs SPY
  7. Oct 5, 20266w ago 8-K Neutral 4/10 Entry $265.06 to $289.60 Now $294.55 +11.12% ▲ +9.26% +12.16% vs SPY
  8. Sep 28, 20267w ago Court Ruling Neutral 2/10 Entry $263.29 to $286.39 Now $294.55 +11.87% ▲ +8.77% +8.06% vs SPY
  9. Sep 14, 20269w ago Court Ruling Neutral Not scored Viewing Entry $261.43 to $272.69 Now $294.55 +12.67% ▲ +4.30% +1.33% vs SPY
  10. Sep 3, 202610w ago 8-K Neutral 4/10 Entry $260.21 to $262.82 Now $294.55 +13.20% ▲ +1.00% +2.19% vs SPY
Showing 10 of 22

US Market Status

Market Closed · Opens Wed (10h 5m)

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
⚖ Court Ruling · govinfo.gov Report published Sep 15, 2026